35 research outputs found
Experience in Managing Severe Malnutrition in a Government Tertiary Treatment Facility in Bangladesh
Children with severe acute malnutrition, defined as weight-for-height <70% of the reference median or bilateral pedal oedema or mid-arm circumference <110 mm having complications, were managed in the Nutrition Unit of the Chittagong Medical College Hospital (CMCH) following the guidelines of the World Health Organization, with support from Concern Worldwide Bangladesh and ICDDR,B. In total, 171 children aged less than five years (mean±SD age 23.5±15.3 months) were admitted during June 2005–May 2006. Of them, 66% were aged less than two years, and 84.2% belonged to households with a monthly income of less than US 14.6 per child or approximately US$ 1 per child-day (excluding staff-cost). Food and medicines accounted for 42% and 58% of the total cost respectively. This study demonstrated the potential of addressing severe acute malnutrition (with complications) effectively with minimum incremental expenditure in Bangladesh. This public-private approach should be used for treating severe acute malnutrition in all healthcare facilities and the treatment protocol included in the medical and nursing curricula
Experience in Managing Severe Malnutrition in a Government Tertiary Treatment Facility in Bangladesh
Children with severe acute malnutrition, defined as weight-for-height
<70% of the reference median or bilateral pedal oedema or mid-arm
circumference <110 mm having complications, were managed in the
Nutrition Unit of the Chittagong Medical College Hospital (CMCH)
following the guidelines of the World Health Organization, with support
from Concern Worldwide Bangladesh and ICDDR,B. In total, 171 children
aged less than five years (mean\ub1SD age 23.5\ub115.3 months) were
admitted during June 2005\u2013May 2006. Of them, 66% were aged less
than two years, and 84.2% belonged to households with a monthly income
of less than US 40. The main reason for bringing children by their
families to the hospital was associated major illnesses:
bronchopneumonia (33%), oedema (24%), diarrhoea (11%), pulmonary
tuberculosis (9%), or other conditions, such as meningitis,
septicaemia, and infections of the skin, eye, or ear. The exit criteria
from the Nutrition Unit were: (a) for children admitted without oedema,
an absolute weight gain of 65500 and 65700 g for children
aged less than two years and 2-5 years respectively; and for children
admitted with oedema, complete loss of oedema and weight-for-height
>70% of the reference median, and (b) the mother or caretaker has
received specific training on appropriate feeding and was motivated to
follow the advice given. Of all the admitted children, 7.6% of parents
insisted for discharging their children early due to other urgent
commitments while 11.7% simply left with their children against medical
advice. Of the 138 remaining children, 88% successfully graduated from
the Nutrition Unit with a mean weight gain of 10.6 g/kg per day
(non-oedematous children) and loss of -1.9 g/kg per day (oedematous
children), 86% graduated in less than three weeks, and the
case-fatality rate was 10.8%. The Nutrition Unit of CMCH also functions
as a training centre, and 197 health functionaries (82 medical
students, 103 medical interns, and 12 nurses) received hands-on
training on management of severe malnutrition. The average cost of
overall treatment was US 14.6 per child or approximately US$ 1 per
child-day (excluding staff-cost). Food and medicines accounted for 42%
and 58% of the total cost respectively. This study demonstrated the
potential of addressing severe acute malnutrition (with complications)
effectively with minimum incremental expenditure in Bangladesh. This
public-private approach should be used for treating severe acute
malnutrition in all healthcare facilities and the treatment protocol
included in the medical and nursing curricula
Study protocol: differential effects of diet and physical activity based interventions in pregnancy on maternal and fetal outcomes--individual patient data (IPD) meta-analysis and health economic evaluation.
© 2014 Ruifrok et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.BACKGROUND: Pregnant women who gain excess weight are at risk of complications during pregnancy and in the long term. Interventions based on diet and physical activity minimise gestational weight gain with varied effect on clinical outcomes. The effect of interventions on varied groups of women based on body mass index, age, ethnicity, socioeconomic status, parity, and underlying medical conditions is not clear. Our individual patient data (IPD) meta-analysis of randomised trials will assess the differential effect of diet- and physical activity-based interventions on maternal weight gain and pregnancy outcomes in clinically relevant subgroups of women. METHODS/DESIGN: Randomised trials on diet and physical activity in pregnancy will be identified by searching the following databases: MEDLINE, EMBASE, BIOSIS, LILACS, Pascal, Science Citation Index, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effects, and Health Technology Assessment Database. Primary researchers of the identified trials are invited to join the International Weight Management in Pregnancy Collaborative Network and share their individual patient data. We will reanalyse each study separately and confirm the findings with the original authors. Then, for each intervention type and outcome, we will perform as appropriate either a one-step or a two-step IPD meta-analysis to obtain summary estimates of effects and 95% confidence intervals, for all women combined and for each subgroup of interest. The primary outcomes are gestational weight gain and composite adverse maternal and fetal outcomes. The difference in effects between subgroups will be estimated and between-study heterogeneity suitably quantified and explored. The potential for publication bias and availability bias in the IPD obtained will be investigated. We will conduct a model-based economic evaluation to assess the cost effectiveness of the interventions to manage weight gain in pregnancy and undertake a value of information analysis to inform future research. SYSTEMATIC REVIEW REGISTRATION: PROSPERO 2013: CRD42013003804.This study was funded by the National Institute for Health Research (NIHR) HTA (Health Technology Assessment) UK programme 12/01
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
Background
Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy
Comparative effectiveness of initial computed tomography and invasive coronary angiography in women and men with stable chest pain and suspected coronary artery disease: multicentre randomised trial
To assess the comparative effectiveness of computed tomography and invasive coronary angiography in women and men with stable chest pain suspected to be caused by coronary artery disease
Erratum to: Study protocol: differential effects of diet and physical activity based interventions in pregnancy on maternal and fetal outcomes: individual patient data (IPD) meta-analysis and health economic evaluation
After publication of this work [1], we noted that we inadvertently
failed to include the complete list of all coauthors
and that sample sizes of some of the trials listed in
Table two were incorrect